Thursday 10th September 2026
10.00
Welcome
10.10
ANCA Vasculites: Towards personalized medicine.
Marta Casal Moura, Mayo Clinic, USA
10.35
ANCA Vasculites: Is there a place for plasmapheresis?
Wladimir Szpirt , ISFA, Copenhagen, Denmark
11.00
Coffee
11.20
Anti-GBM: Presenting data from GOOD-Ides 2.
Professor Mårten Segelmark, Lund University, Sweden
11.45
Lupus Nephritis: Time to redefine treatment goals.
Fernando C. Fervenza, Mayo Clinic, USA
12.10
CAR-T cells therapy: Nephrotoxicity and future use for autoimmune diseases.
Sandra Herrmann, Mayo Clinic, USA
12.35
Lunch
13.30
Treatment of IgA nephropathy not based in KDIGO.
Fernando C. Fervenza, Mayo Clinic, USA
13.55
Advanced molecular profiling of FFPE kidney biopsies.
Assistant Professor Øystein Solberg Eikrem, Department of Clinical Medicine, University of Bergen, Norway
14.20
Membranous Nephropathy: Discovery of new target antigens and what they mean.
Sanjeev Sethi, Mayo Clinic, USA
14.45
Coffee
15.15
Pregnancy and Renal Disease.
Vesna Garovic, Mayo Clinic, USA
15.45
What happens after hypertensive disorders of pregnancy?
Andrea Kattah, Mayo Clinic, USA
16.10
Nephrotoxicity of Immune Checkpoint Inhibitors.
Sandra Herrmann, Mayo Clinic, USA
Friday 11th September 2026
9.15
Genetics and cystic kidney diseases.
Peter Harris, Mayo Clinic, USA
9.40
Personalized approach for the treatment of kidney stone disease.
John Lieske, Mayo Clinic, USA
10.05
The neglected anion sulfate - new links between the kidney and extrarenal disease.
Felix Knauf, Mayo Clinic, USA
10.30
Coffee
11.00
CKD-associated osteoporosis; Updated clinical approach and treatment.
Professor Ditte Hansen, Herlev Hospital, Denmark and Ass. Professor Hanne S Jørgensen, Aarhus University hospital, Denmark
11.25
Role of Inflammation, Uremic Toxins and Senescence for Early Vascular Ageing in CKD.
Professor Peter Stenvinkel, Karolinska University Hospital, Stockholm, Sweden
11.50
Future perspectives in kidney protection in diabetes.
Professor Peter Rossing, Steno Diabetes Center, Copenhagen, Denmark
12.15
Lunch
13.15
Beware the generics – cheaper but not necessarily safe! -simultaneous bioequivalence assessment of tacrolimus and mycophenolate mofetil in steady-state kidney transplant recipients.
Professor Anders Åsberg, Department of Transplantation, Oslo University Hospital - Rikshospitalet, Norway
13.40
Hypoimmune pancreatic islet transplantation in type 1 diabetes.
Professor Hanne Scholz, Experimental Cell Transplantation Research Group, Department of Transplantation Medicine, Oslo University Hospital, Norway
14.05
Coffee
14.30
The use of AI-based image analysis to improve kidney care in patients.
Andrew Rule, Mayo Clinic, USA
14.55
Artificial Intelligence in Nephrology: Current Applications and Future Directions.
Wisit Cheungpasitporn, Mayo Clinic, USA